The Fellow on Call: The Heme/Onc Podcast Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy
Dec 18, 2024
Explore innovative treatment strategies for elderly patients with acute myeloid leukemia who can't handle intensive therapy. Learn about assessing fitness for treatment and the significance of genetic mutations. Discover how modern therapies like azacitidine and venetoclax are reshaping care for frail patients. Key clinical trials, including Viali-A and LACEWING, reveal improved outcomes. The episode delivers valuable insights into navigating the complexities of AML management in older, less fit patients.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 2min
Assessing Treatment Options for Older Patients with Acute Myeloid Leukemia
01:39 • 3min
Clinical Considerations for Treating Frail Patients in Oncology
04:35 • 5min
The Evolution of AML Treatment for Less Fit Patients
09:32 • 5min
Advancements in AML Treatment for Fragile Patients
14:48 • 18min